Pramipexole CAS 104632-26-0
Synonyms: Mirapex, Mirapexin, Sifrol;
CAS Number: 104632-26-0
Molecular Weight: 211.324 g/mol
Molecular Formula: C10H17N3S
Appearance: white crystalline powder
Pramipexole (Mirapex, Mirapexin, Sifrol) is a dopamine agonist of the non-ergoline class indicated for treating Parkinson's disease (PD) and restless legs syndrome (RLS).
Pramipexole is the generic name for the prescription drug Mirapex, which is used to treat symptoms of Parkinson's disease and restless leg syndrome (RLS).
Mirapex belongs to a class of drugs called dopamine agonists. Scientists believe that it encourages dopamine activity in the body by increasing the sensitivity of dopamine receptors.
In the brain, dopamine acts as a neurotransmitter — helping nerves communicate — which improves movement in restless leg syndrome and helps relax tremors in Parkinson's disease.
Originally manufactured by Boehringer Ingelheim under the brand name Mirapex, pramipexole was first approved by the Food and Drug Administration (FDA) in 1997.